Podcasts about Lymphoma

In this week's episode, Blood editor Dr. Philippe Armand interviews Drs. Manali Kamdar and Nancy L. Bartlett on their latest review article published in Blood titled “From breakthroughs to blueprints: evolving evidence and future directions in relapsed and refractory large B-cell lymphoma”. They discuss the how the advent of chimeric antigen receptor T cells, antibody-drug conjugates, and bispecific antibodies all show major increases in efficacy over legacy chemotherapy-based regimens. They also share their insights on how to transform treatment paradigms in light of these breakthroughs.

In 2008, Elaine Gibson was diagnosed with Stage IV Non-Hodgkin's Lymphoma and told she wouldn't live to see her grandchildren grow up. After experiencing this recurrence, she refused to accept that prognosis and turned to nature and the body's innate wisdom. Through Dr. Otto Warburg's research, she discovered how oxygen and cellular health are key to healing. While all the Radical Remission Healing Factors are part of her lifestyle, changing her diet, taking control of her health, and deepening her spiritual connection became the foundation of her healing journey. Today, Elaine is cancer-free and a green-juice-loving grandmother, and creator of the Starving Cell Recovery Method™.  Elaine now guides women to master a lifestyle that creates a body where cancer cannot grow, helping them live with energy, clarity, and peace of mind—without giving up chocolate—on and off the pickleball court. https://renewedlivinginc.com/ https://www.facebook.com/elaine.gibson.188; https://www.instagram.com/elaine_gibson_gaga/  Free Gift: https://renewedlivinginc.com/starving-cell-recovery-system-radical-remission/  _______ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com.   To learn more about Radical Remission health coaching with Liz or Karla, Click Here   Join our mailing list and you'll receive our free eBook, Kickstart Your Healing: 20 Radical Remission Tips, as a special thank you for joining. Subscribe Here   To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here. To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning. Follow us on Social Media: Facebook  Instagram YouTube ______ Our Sponsor: Nestled in the pristine, natural beauty of British Columbia, The Healing Oasis stands as Canada's first-of-its-kind cancer wellness retreat, where hope reignites and the body is empowered to heal. Here, our renowned naturopathic cancer expert, Dr. Sean Ceaser, designs a fully personalized protocol of advanced, non-toxic therapies—including high-dose IVs like mistletoe and vitamin C, cutting-edge hyperthermia, PEMF, oxygen therapy, red light, and more. Savor daily organic, cancer-fighting meals, rest deeply in serene cabins, immerse in restorative activities like forest walks and yoga, drink mineral-rich living water, and receive emotional support in a peaceful sanctuary that combines world-class care with profound nature immersion to reduce side effects, boost vitality, and spark radical healing. Your journey to feeling alive again begins today at thehealingoasis.ca. Learn More about The Healing Oasis: Website   Testimonials Video Overview

Yah Welcome Wednesday It has been a question that's been hitting our inbox since we started and today we answer it, today we discuss the idea of welcoming a female voice on the show!... New Zealand has always been portrayed as a sporting country but is that really the case?... The Shifters are given a chance to ask us anything and well, we have to answer!... The Speights Men's Den is a powerful one, as Shift Nation. We have the opportunity to come together and help one of our own, Mike... Mike has been battling Non -Hodgkin's Lymphoma since March 2025 and is in need of treatment that requires him to go overseas but the thing is, it isn't cheap... Shift Nation let's do what we do best and come together to help, but the time to help Mike is now! (Link Below To Donate) Shift Nation, Any donations are more than appreciated! If you would like to donate to help Mike, tap the link below! https://givealittle.co.nz/cause/help-mikey-reach-his-car-t-therapy-overseas Hit that link below to stay caught up with anything and everything TMS. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.facebook.com/groups/3394787437503676/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We dropped some merch! Use TMS for 10% off. Here is the link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://youknowclothing.com/search?q=tms⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Thank you to the team at Chemist Warehouse for helping us keep the lights on, here at The Morning Shift... ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.chemistwarehouse.co.nz/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 00:00 - INTRO 2:44 - CHECK IN (WORLD CUP FEVER) 11:52 - DAILY BREAD 19:30 - SHIFTERS ASK, WE ANSWER 38:03 - SPEIGHTS MEN'S DEN 44:19 - OUTRO Learn more about your ad choices. Visit megaphone.fm/adchoices

In this Review series episode, Blood associate editor Dr. Diane Krause interviews contributing authors from the Review Series on Clonal tracking in Hematopoiesis published in volume 147 issue 23 of Blood. Dr. Alejo E. Rodriguez-Fraticelli speaks to the development of his paper, "Clonal tracing of blood stem cells across mouse and human lifespans”, which provides a detailed overview of the experimental approaches that make clonal analysis possible, and which approaches are most appropriate to use to address specific questions. Dr. Shalin H. Naik speaks about how different clonal tracking approaches have been used to address the central question of clonal fate specification of stem and progenitor cells to specific lineages in “The evolution of hematopoietic models through a clonal lens”. Finally, Dr. Federico Gaiti speaks about “Methylation-based lineage tracing in cancer”, which takes these ideas into the context of cancer, focusing on how DNA methylation can be used to reconstruct clonal relationships.  

In a special cobranded episode between Oncology on the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)'s program ASTCT Talks, host Rahul Banerjee, MD, FACP, spoke with colleague Hitomi Hosoya, MD, PhD, about a study she and coauthors published in Blood. In their study, Hosoya and colleagues assessed the underlying mechanisms of chimeric antigen receptor (CAR) T-cell–related lymphomas developing in the gastrointestinal (GI) tract. The study focused on a particular case involving a 50-year-old patient with relapsed/refractory multiple myeloma who developed T-cell lymphoma after receiving cellular therapy in the seventh-line setting. Listen below or via your favorite podcast platform.

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Johnny Mahlangu and Joseph Rocco on their articles published in volume 147 issue 9 of Blood.  Dr. Mahlangu discusses study details and next steps from "Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial" which shows that bleeding was reduced by 93% with subcutaneous marstacimab. Dr. Rocco shares the development behind "CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis", and the insights gained from measuring a new surrogate marker of IFN-γ activity predicting severity and mortality.

Friday - Clark Stinks day! Christa shares Clark Stinks posts with Clark. Submit yours at Clark.com/ClarkStinks.    Also, while many of us use fitness trackers to count steps or monitor sleep, the latest data shows some of these devices are evolving into genuine lifesavers. Clark has worn a Garmin for twenty years and a Samsung smartwatch, but the Oura Ring has truly impressed him and for good reason, as new findings indicate.   Clark Stinks: Segments 1 & 2 Oura Reports: Segment 3 Ask Clark: Segment 4 Mentioned on the show: Is Turo Legit? 5 Things To Know Before You Use It 5 of Clark Howard's Most Extreme Frugal Hacks What Is Umbrella Insurance and Do You Need It? - Clark Howard The Insurance Policies You Need (and Some You Don't) What Age Are Americans Actually Starting Social Security? Term Life vs. Whole Life Insurance: Understanding the Difference Oura Ring Helps Uncover 'Multiple Cases of Lymphoma,' Says Its Chief Medical Officer Axios: Finish Line: The quiet rise of "prescribing connection" 4 Ways To Stop Junk Mail - Clark Howard How To Choose the Best Charities for Your Donations - Clark Howard Memorial Day 2026: Facts, Meaning & Traditions Clark.com resources: Episode transcripts Community.Clark.com  /  Ask Clark Clark.com daily money newsletter Consumer Action Center Free Helpline: 636-492-5275 Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us Fan MailOn this episode, I sit down with Jules Peters, the wife of the front man of The Alarm, the late Mike Peters. We discuss their incredible love affair, his long battle with cancer, The Alarm's new album, Transformation, and more.****"Mike lived a life of beauty and never gave up right to the very end,” says Jules Peters, bandmate and wife of the late Mike Peters of THE ALARM who passed away on April 29, 2025. Following a fearlessly valiant 31-year battle with cancer, his monumental legacy continues with the release of TRANSFORMATION on May 29, 2026 on Twenty First Century Recordings/Virgin Music Group. Its latest single, “Live Today” premieres now via Consequence.Filmed just days before Mike underwent the innovative CAR-T treatment with hopes of eradicating Richter's Syndrome, an aggressive form of lymphoma, “Live Today” is Mike's final video. “As the sun rose, watching Mike perform this song with so much optimism and hope will live with me forever,” said Jules as she looks back. “It was a bittersweet day for me as we filmed this incredible joyous film on the beach in the North of England. After filming concluded, we climbed onto the tour bus and drove straight to the Christie Hospital in Manchester, U.K.. We were full of determination that the pioneering CAR-T would save Mike's life but, at the same time, I was personally terrified as I couldn't shake off a feeling that cancer had finally caught up with us both.”Diagnosed with lymphoma in 1995 and later with chronic lymphocytic leukemia, Peters refused to let his illness silence him. Instead, he turned his fight into a mission to help others.Alongside his wife Jules, he co-founded Love Hope Strength, a music-driven cancer charity that revolutionized awareness and action around stem cell donation that continues beyond his passing. Through its innovative “Get On The List” campaigns—often hosted at rock concerts and even atop mountains—the charity has added over 400,000 people to the global stem cell registry and helped secure thousands of potential life-saving matches for patients worldwide. While this may seem like the final chapter for The Alarm, Transformation promises that the legacy of The Alarm will transform into something larger. While Mike has gone out in a blaze of glory, his love, hope and strength continues on. Echoing the title of the new single, Jules concludes, “Mike and the spirit of The Alarm will ‘Live Today,' forever more. I invite you all to blast Transformation out loud. Imagine Mike in the room with you. Transformation is his battle cry, his resilient love of life. Right to the very end, Mike believed that he was going to live, to be totally free. My last memory is driving him open top along the North Wales coast road, playing Transformation at maximum volume. He was so happy. So full of life. Playing his air drums, bass guitar, already imagining himself on his next world tour. So keep that positive spirit moving forwards. Imagine him as you all knew him best, striding out on to that stage, changing lives one concert at a time. This is an album of hope and a passionate celebration of a life well lived. Please do not be sad. Mike wouldn't want that. He was so proud of this album and had the best time recording it during the last six months of his life. Blast it out loud like Mike did. Play along to the track list and most of all, be happy that we all had Mike in our lives and continue to do so. The music of Mike and The Alarm will always keep us strong”.****If you would like to contact the show Dauna@betertopodcast.comFollow us on Social MediaYouTube: https://www.youtube.com/channel/UCX0ETs2wpOHbCuhUNr0XFTw?view_as=subscriberInstagram: https://www.instagram.com/author_d.m.needom/Facebook: https://www.facebook.com/bettertopodcastwithdmneedomSupport the podcast here: https://www.patreon.com/bettertopodcastwithdmneedom©2026 Better To...Podcast with D. M.NeedomSupport the show

 In this episode, Blood deputy editor Dr. Helen Heslop interviews contributing  authors from the Blood review series on hemophagocytic lymphohistiocytosis. Drs. Nancy Berliner and Joanne Hsu join to provide insight on their paper, “Hemophagocytic lymphohistiocytosis in adults” discussing the importance of prompt diagnosis and treatment in this high-mortality disorder, and highlight emerging agents designed to modulate disease progression. Drs. Carl Allen and Bethany Verkamp reimagine diagnostic criteria through a threshold model in “Pediatric hemophagocytic lyphohistiocytosis: current conceptualization, diagnosis, and treatment”, in order to provide individualized therapies with the goal of addressing the combined influence of genetic susceptibility and environmental triggers.

What happens when a medical doctor trained in oncology becomes the cancer patient and then transforms into a primary caregiver for his own father? In this moving continuation of our conversation with clinician, survivor, and care partner Dr. Achim, we dive into the profound emotional architecture of navigating a cancer diagnosis. Dr. Achim opens up about the vast difference between his first experience as a helpless care partner for his father's prostate cancer in 2010, and his recent role guiding his 85-year-old father through aggressive lymphoma and groundbreaking CAR T-cell therapy.Samira and Dr. Achim explore a topic rarely discussed openly in the oncology world: the long, arduous journey of rebuilding trust in your body after it feels like it has completely betrayed you. Dr. Achim shares how shifting from anger to radical self-love and mastering the art of strict presence—learning to live purely in the current moment—became his ultimate armor against the paralyzing fear of cancer recurrence. Whether you are a patient looking for tools to manage treatment intervals, a male patient looking for permission to voice your fears, or a caregiver trying to balance medical advocacy with emotional support, this episode offers an essential roadmap for finding steady footing when your world is turned upside down.Chapter Codes:00:00 Grounding in the Present Moment00:44 Dr. Achim's Transition From Patient to Caregiver02:15 The Reality of Being a Cancer Care Partner06:46 Navigating Aggressive Lymphoma & CAR T-Cell Therapy09:57 Healing the Feeling of "Body Betrayal"13:49 Mind-Body Visualizations During the Treatment Time Gap15:36 Overcoming the Fear of Cancer Recurrence19:33 Mental Health Stigmas for Male Cancer Patients25:25 Life with No Evidence of Disease (NED)Key Takeaways from This Episode:The Caregiver Shift: Why true caregiving isn't about having all the answers or trying to "fix" the disease; it is about steady, radical presence and holding a hand through the confusion.The "Betrayal" of the Body:Understanding the mental shift required to stop treating your body like an enemy and realizing that it is still actively fighting for you.The Power of Visualizations:How Dr. Achim used a 5-day Carl Simonton method seminar to train his mind during the critical "time gap" between diagnosis and treatment.Connect with Manta Cares & Patient from Hell:Learn more about our mission: Manta Cares WebsiteDiscover your personal cancer roadmap: Patient from Hell Podcast HubSubscribe, rate, and review on Apple Podcasts, Spotify, and YouTube!Disclaimer: This podcast, show notes, and newsletter are for general informational purposes only and do not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. The use of information on this podcast or any materials linked from it is at the user's own risk. The opinions of the speakers are their own and do not represent the organizations they are affiliated with, nor do they reflect the opinions of Manta Cares Inc. or its sponsors.

Today's guest is Carmen Monge, Hodgkin's Lymphoma survivor, researcher, and patient advocate working at the intersection of lived experience, research, and equity in cancer care, especially across different global healthcare systems.Carmen is the founder of MANO Beyond Cancer, a global initiative exploring survivorship through qualitative research, where she had conducted interviews with survivors from more than 60 countries. She also works as a researcher and patient advocate with Youth Cancer Europe. And the author of CAN-CAN, a children's book series designed to help explain the cancer journey, from diagnosis to life after treatment, in a holistic and accessible way.We talk about hope, cancer research, cultural differences and disparities in cancer care, the challenges of getting treatment is another country from your homeland, common threads among survivors globally, and so much more!!!Resources:Carmen's YouTube channel: https://www.youtube.com/@MANObeyondcancerCarmen's Instagram: https://www.instagram.com/mano_beyondcancer/Carmen's contact info: https://linktr.ee/CarmenMongeFollow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

In this pre-recorded episode, I sit down with Steve Hobson — organiser of Cancer Puncher and drummer of Bad Boat — alongside Carl King of Two Tales of Woe and Gareth Ruddock of Sky Pilot to talk all things Cancer Puncher 2. We discuss how the original Cancer Puncher charity event came together following the diagnosis of Lymphoma in Haint frontman Ian, as well as the impact cancer has had on friends, family and members of the local music scene. Steve opens up about organizing the first event, the incredible response from bands and fans, and raising more than €3,000 for Cancer Focus NI, Belfast City Hospital Cancer Unit and Southern Hospice Trust. The conversation also covers the upcoming Cancer Puncher 2 event, the importance of the Metal and alternative scene pulling together for charity, raffle prizes donated by bands including Therapy?, Ten Ton Slug and Slomatics, and why this final event means so much to everyone involved. Topics include: Cancer Puncher 2 charity event Bad Boat reunion Northern Ireland metal scene Two Tales of Woe interview Sky Pilot interview Charity fundraising through music Cancer awareness and community support Local bands supporting Cancer Focus NI Underground metal and alternative music in Ireland Tickets Link: https://www.eventbrite.com/e/cancer-puncher-ii-tickets-1984458781636 If you enjoy grassroots music, Northern Ireland metal, charity events, podcasts, band interviews and the DIY scene, make sure to like, comment and subscribe. CancerPuncher2 #livemetal #metalcommunity #irishmetal #metal #metalpodcast #charityconcert #alternativemusic #belfast #cancerawareness #heavymusic #podcastinterview

In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Reuben Kapur and Robert Campbell on their latest articles published in Blood. This episode highlights two groundbreaking studies exploring how inflammation drives serious blood and immune-related diseases. In the first interview, Dr. Kapur discusses how inflammatory bowel disease (IBD) can both promote and worsen clonal hematopoiesis of indeterminate potential (CHIP), with large-scale human data and mouse models identifying REF1 as a key mediator and potential therapeutic target. The second segment features Dr. Campbell, who explains how heme released during malaria infection activates platelet mTOR signaling, intensifying cerebral malaria and suggesting new avenues for platelet-targeted treatments. Together, the conversations reveal how inflammatory pathways and immune signaling contribute to disease progression while opening the door to novel precision therapies. 

Link Up w/The Morning Sickness Digitally All Over:Instagram: @hms_98_official, @bosskupd, @bretvesely, @dickToledoX/Twitter: @HMSon98, @DickToledo, @bretveselyFacebook: @HMSKUPDYouTube: @hmspodcast9320, @98kupdRequest/Call in/Wakeup Song line:(IN AZ) 602.585.9800More HMS: holmbergpodcast.com, 98kupd.comEmail: dtoledo@98kupd.com, bvesely@98kupd.com, bbogen@98kupd.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Link Up w/The Morning Sickness Digitally All Over:Instagram: @hms_98_official, @bosskupd, @bretvesely, @dickToledoX/Twitter: @HMSon98, @DickToledo, @bretveselyFacebook: @HMSKUPDYouTube: @hmspodcast9320, @98kupdRequest/Call in/Wakeup Song line:(IN AZ) 602.585.9800More HMS: holmbergpodcast.com, 98kupd.comEmail: dtoledo@98kupd.com, bvesely@98kupd.com, bbogen@98kupd.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BWH865. CME/MOC/AAPA/IPCE credit will be available until May 5, 2027.Raising the CAP on Lymphoma Care: Community–Aligned Principles for Integrating CELMoDs Into Real-World Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BWH865. CME/MOC/AAPA/IPCE credit will be available until May 5, 2027.Raising the CAP on Lymphoma Care: Community–Aligned Principles for Integrating CELMoDs Into Real-World Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

Would like like to share feedback on this podcast? Or suggest another topic for us to explore? Click here, or email us at DocTalk@medstar.netOn this DocTalk episode, we chat with Dr. Joseph Roswarski, the lymphoma/leukemia attending at MedStar Georgetown University Hospital and the Georgetown Lombardi Comprehensive Cancer Center. Dr. Roswarski's medical career includes clinical care and research in hematologic malignancies, particularly lymphoma and multiple myeloma. For an interview with Dr. Joseph Roswarski, or for more information about this podcast, contact MedStar Georgetown University Hospital Manager Media Relations, Ryan.M.Miller2@Medstar.net. Learn more about Dr. Roswarski.For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BWH865. CME/MOC/AAPA/IPCE credit will be available until May 5, 2027.Raising the CAP on Lymphoma Care: Community–Aligned Principles for Integrating CELMoDs Into Real-World Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BWH865. CME/MOC/AAPA/IPCE credit will be available until May 5, 2027.Raising the CAP on Lymphoma Care: Community–Aligned Principles for Integrating CELMoDs Into Real-World Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

The U.S. Food and Drug Administration, or FDA, has had a busy first quarter…

The U.S. Food and Drug Administration, or FDA, has had a busy first quarter of 2026 approving medications for the animals that we care so much about. In early March—and...

In this week's episode, Blood editor Dr. Laura Michaelis interviews Dr. Alexis Thompson, former ASH president, on her latest article published in Blood. Dr. Thompson discusses "Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia." She explains transfusion-dependent β-thalassemia (TDT) requires rigorous, lifelong transfusion therapy and iron chelation to manage iron overload. Dr. Kwiatkowski and colleagues discuss the long-term efficacy and safety of this gene therapy in 63 patients with TDT, documenting sustained transfusion independence for up to 10 years and a safety profile consistent with that of myeloablative autologous transplantation.

Ep. 204 - In this powerful episode, Kimberly sits down with Charles Porter, a man of "many talents and mysteries." From his dual citizenship and elite football career at Duke University to a 17-year battle with Stage IV Hodgkin's Lymphoma, Charles shares a masterclass in resilience, the power of brotherhood, and a concept he calls "brainwashing yourself for greatness." Chapter Timestamps: 0:44 - How Childhood Trauma Becomes a Gift 2:12 - Prep School: Exposure to a Different World 3:23 - Football at Duke University & The Power of Teamwork 4:44 - Why I Moved to Hollywood with No Plan 9:32 - Beg, Borrow and Deal: My Start in Reality TV 12:49 - The Bond of Brotherhood: "We Go Hard for Each Other" 16:04 - Pouring Champagne for Eddie Murphy & Celebrity Insight 19:13 - The Ari Emanuel Story: Hanging Up on a Power Agent 21:14 - The Diagnosis: Stage 4 Cancer at Age 30 23:44 - The Essence of Self: Stripped of Physical Identity 26:15 - Brainwashing Yourself for Greatness 28:47 - Parenting Through Chronic Illness 32:13 - The Power of All-In Boundaries 35:32 - Using Stoicism & Visualization to Heal 38:43 - Facing Sepsis: Protecting Your Mental Space 43:03 - Handling Mischaracterization & Character Assassination 45:33 - Charles's "Must-Read" Book Recommendations Follow Charles on Instagram: https://www.instagram.com/cfpgram/ And Black Bench Productions: https://www.instagram.com/p/DPAOvZAEgK2/?img_index=1 Follow Kimberly on Instagram: https://www.instagram.com/kimberlylovi/ Subscribe on YouTube Here:  ⁨https://www.youtube.com/@iconicnationmedia

"I knew the diagnosis, the prognosis, and the five-year survival rates. And for the first time, knowing more didn't help, it made it worse."In this powerful episode of The Patient From Hell, host Samira sits down with Dr. Achim Zinggrebe, a German physician and pharmaceutical oncology expert who found himself on the other side of the stethoscope. After years of treating cancer and developing oncology drugs, Dr. Achim discovered fist-sized lymph nodes on his own MRI, leading to a diagnosis of advanced lymphoma with a 1-to-2-year survival outlook.Dr. Achim shares a raw, clinical, and deeply personal look at the "curse of knowledge" that comes when a doctor becomes the patient. We dive into the "mirror moment" that changed his trajectory, the scientific proof behind integrative therapies like meditation, and why the current medical system often fails to address the "mind and soul" of the person behind the pathology.In this episode, we discuss:The surreal experience of reading your own terminal cancer scans.Why "Dr. Google" is a universal trap, even for medical experts.The transition from conventional oncology to an integrative "Body, Mind, and Soul" approach.The "Mirror Moment": How to start fighting for yourself instead of everyone else.Crucial advice for clinicians on empathy, silence, and treating the human, not just the lab results.Guest Bio:Dr. Achim Zinggrebe is a physician, cancer survivor, and family member of a cancer patient. He works at the intersection of medicine, lived experience, and human reality.Having seen cancer from all three perspectives, his work focuses on helping people find clarity, inner stability, and direction in a time that often feels uncertain. He is the author of Rise and Thrive Above Cancer and the Rise and Thrive Journal, and the creator of a structured pathway that supports people during and beyond treatment in a grounded and honest way.Dr. Achim Zinggrebe joins us from Southern Germany to share how he transformed a devastating prognosis into a mission to provide a "shortcut" for other patients through his upcoming book and advocacy.Chapter Codes00:00 - The MRI That Changed Everything00:44 - Introducing Dr. Achim: Physician, Survivor, & Caregiver02:02 - From Paramedic to Oncology: A Career Built on Helping04:01 - The Diagnosis: Advanced Lymphoma05:30 - Ignoring the Signs: Why We Put Ourselves Last06:07 - The Curse of Knowledge: Why Knowing the Survival Rates is a Burden08:04 - Seeking Hope in a 2-Year Prognosis10:49 - What Medical School Never Taught Me About Being a Patient12:37 - The Missing Piece in Oncology: Body, Mind, and Soul15:12 - The Mirror Moment: Redefining the Role of Medicine18:30 - Rebuilding Your Identity After a Diagnosis22:51 - The Science of Integrative Medicine & Meditation26:53 - Advice to Clinicians: Listen More, Talk Less28:47 - The System vs. The Human BeingSupport the Podcast:If you found this story inspiring, please Like, Subscribe, and hit the Notification Bell. Sharing these stories helps break the stigma surrounding lung cancer and provides a community for those in the fight.#LungCancer #PatientStories #DoubleLungTransplant #CancerAdvocacy #PatientFromHell #ManticareDisclaimer:This podcast, show notes, and newsletter are for general informational purposes only and do not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice; no doctor-patient relationship is formed. The use of information on this podcast or any materials linked from this blog is at the user's own risk. The opinions of the speakers are their own and do not represent the opinions of organizations they are affiliated with, nor do they reflect the opinions of Manta Cares Inc. or Manta Cares' sponsors.

One heavy squat at 400 pounds was all Kalil Sherrod needed to know the poison hadn't won. Seven weeks before this recording, Kalil walked into elitefts HQ to hit his first major milestone since a brutal cancer diagnosis. That moment bridged the gap between his life as an elite performance coach and his reality as a survivor. Through two stem cell transplants and multiple rounds of high-intensity chemotherapy, he developed a conjugate-based survival blueprint—one that reinforces a hard truth: muscle mass is one of the most powerful insurance policies for the human body. Inside the Episode: The 93% Rule: Why maintaining a high performance floor matters more than chasing a peak during a competitive season Conjugate for the Court: Applying Westside methodology to basketball players without sacrificing vertical jump or shooting touch Training Through the Storm: How Kalil adjusted his training split during "ICE" chemotherapy to preserve lean tissue The Youth Development Gap: Why the loss of PE and martial arts is producing more fragile athletes—and how to reverse it The IV Protocol: A critical hydration strategy often overlooked during medical treatment Meet the Guest: Kalil Sherrod is a high-performance coach, author, and founder of Revenants Coaching. A former Division II basketball player, he serves as a Sports Performance Coach for the Thailand Titans and works with athletes at The Spot Athletics. He is the author of The Basketball Player's Training Guide and co-author of the elitefts eBook Mastering Conjugate Programming for Athletes. After surviving Hodgkin's Lymphoma, Kalil has dedicated his work to helping athletes and survivors use strength as a foundation for resilience. Connect with Kalil Sherrod: Instagram: https://www.instagram.com/kalil_sherrod YouTube: https://www.youtube.com/@kalilsherrod4882 Linktree: https://linktr.ee/kalilsherrod The Get Clean Podcast: https://podcasters.spotify.com/pod/show/kalil-sherrod7 The Spot Athletics: https://www.thespotathletics.com Revenants Coaching: https://linktr.ee/kalilsherro Become an elitefts Channel Member: Get early access to Dave Tate's Table Talk and more: @eliteftsofficial Support Dave Tate's Table Talk: FULL Crew Access: https://www.elitefts.com/join-the-crew Limited Edition Apparel: https://www.elitefts.com/shop/apparel/limited-edition.html Programs & More: https://www.elitefts.com/shop/dave-tate-s-table-talk-crew.html TYAO Application: https://www.elitefts.com/dave-tate-s-tyao-application Best-Selling elitefts Products: Pro Resistance Bands: https://www.elitefts.com/shop/bands.html Specialty Barbells: https://www.elitefts.com/shop/bars-weights/specialty-bars.html Wraps, Straps, Sleeves: https://www.elitefts.com/shop/power-gear.html Sponsors: Get an extra 10% OFF at elitefts (CODE: TABLE TALK): https://www.elitefts.com/ Get 10% OFF Marek Health Labs (CODE: TABLETALK): https://marekhealth.com/tabletalk Free 8-count LMNT Sample Pack: http://www.drinklmnt.com/tabletalk Support Massenomics: https://www.massenomics.com/ Save 20% on MASS Research Review (CODE: ELITEFTS20): https://massresearchreview.com/ Get 10% OFF RP Hypertrophy App (CODE: TABLE TALK): https://rpstrength.com/pages/hypertrophy-app

One heavy squat at 400 lbs was the only signal Kalil Sherrod needed to know the poison hadn't won yet. Seven weeks before recording this episode, Kalil walked into elitefts HQ to hit his first heavy milestone since a grueling cancer diagnosis—a moment that bridged the gap between his life as an elite performance coach and his reality as a survivor. Through two stem cell transplants and rounds of high-intensity chemo, he has refined a conjugate-based survival blueprint that proves muscle mass is the ultimate insurance policy for the human immune system. INSIDE THE EPISODE: The 93% Rule: Why maintaining a high performance floor is more critical than chasing a ceiling during a competitive season. Conjugate for the Court: How to apply Westside methodology to basketball players without sacrificing their vertical or shooting touch. Training Through the Storm: The specific adjustments Kalil made to his training split while undergoing "ICE" chemotherapy to preserve lean tissue. The Youth Developmental Gap: Why the loss of traditional PE and martial arts is creating a generation of fragile athletes and how to fix it. The IV Protocol: A critical, overlooked hydration tip for anyone navigating medical treatments that often gets ignored by hospital staff. MEET THE GUEST: Kalil Sherrod is a high-performance coach, author, and the founder of Revenants Coaching. A former DII basketball player, he currently serves as the Sports Performance Coach for the Thailand Titans professional basketball organization and coaches at The Spot Athletics. Kalil is the author of The Basketball Player's Training Guide and co-author of the elitefts eBook Mastering Conjugate Programming for Athletes. After surviving Hodgkin's Lymphoma, he has dedicated his work to helping athletes and fellow survivors use strength as a tool for radical resilience. CONNECT WITH KALIL SHERROD: Instagram: https://www.instagram.com/kalil_sherrod YouTube: https://www.youtube.com/@kalilsherrod4882 Linktree: https://linktr.ee/kalilsherrod The Get Clean Podcast: https://spotify.com/0 The Spot Athletics: https://www.thespotathletics.com Revenants Coaching: https://linktr.ee/kalilsherro SUPPORT DAVE TATE'S TABLE TALK: FULL Crew Access: https://www.elitefts.com/join-the-crew Limited Edition Apparel: https://www.elitefts.com/shop/apparel/limited-edition.html Programs & More: https://www.elitefts.com/shop/dave-tate-s-table-talk-crew.html TYAO Application: https://www.elitefts.com/dave-tate-s-tyao-application ELITEFTS GEAR: Pro Resistance Training Bands: https://www.elitefts.com/shop/bands.html Specialty Barbells: https://www.elitefts.com/shop/bars-weights/specialty-bars.html Wraps, Straps, Sleeves: https://www.elitefts.com/shop/power-gear.html SPONSORS: elitefts: (CODE: TABLE TALK) https://www.elitefts.com/ Marek Health Labs: (CODE: TABLETALK) https://marekhealth.com/tabletalk LMNT: (Free Sample Pack) http://www.drinklmnt.com/tabletalk Massenomics: https://www.massenomics.com/ MASS Research Review: (CODE: ELITEFTS20) https://massresearchreview.com/ RP Hypertrophy App: (CODE: TABLE TALK) https://rpstrength.com/pages/hypertrophy-app

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Francesco Forconi and Bin Guo on their latest articles published in Blood. Dr. Guo shares insights from "Nucleoplasmic ZNF467 condensates boost hematopoietic stem cell engraftment via ICAM1-mediated mechanical reprogramming". The findings establish biomechanical regulation as an important determinant of stem cell identity and reveal new strategies for engineering stem cells with enhanced regenerative capacity. Then, Dr. Forconi discusses "DC-SIGN binding to the surface immunoglobulin oligomannose-type glycans promotes follicular lymphoma cell adhesion and survival". Persistent, low-level BCR engagement by DC-SIGN enables FL tissue retention and survival while avoiding the deleterious proapoptotic consequences of stronger, conventional antigen-driven BCR signaling. These findings help explain how FL cells exploit their microenvironmental niche.

In a special cobranded episode between Oncology On the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)'s program ASTCT Talks, host Rahul Banerjee, MD, FACP, spoke with colleague Hitomi Hosoya, MD, PhD, about a study she and coauthors published in Blood. In their study, Hosoya and colleagues assessed the underlying mechanisms of CAR T-cell–related lymphomas developing in the gastrointestinal tract. The study focused on a particular case involving a 50-year-old patient with relapsed/refractory multiple myeloma who developed T-cell lymphoma after receiving cellular therapy in the seventh-line setting. The discussion began with an overview of the patient's treatment course, who initially responded well to seventh-line CAR T-cell therapy and experienced grade 1 cytokine release syndrome with no neurotoxicity. Two months after initiating this line of therapy, the patient experienced diarrhea and subsequent hospitalization. Following multiple endoscopies and the use of steroids and other biologic agents, the patient's diarrhea persisted, which resulted in notable weight loss and cachexia. A biopsy revealed that the patient had developed T cell infiltration in the small intestine, which correlated with an eventual diagnosis of T-cell lymphoma. After the patient's diagnosis, Hosoya outlined her team's decision to administer cyclosporine to help mitigate and eventually resolve the patient's diarrhea. Beyond this symptom management, she highlighted the challenges of treating those with GI-related T-cell lymphomas based on a lack of sufficient treatment protocols and clinical experience across the country. Overall, she emphasized teamwork as an essential component of managing and further understanding CAR T-cell lymphomagenesis.Banerjee is an assistant professor in the Clinical Research Division at the Fred Hutchinson Cancer Center and a member of the ASTCT Content Committee. Hosoya is a principal investigator in Hematology & Cellular Therapy at Cedars-Sinai Medical Center and an instructor of Blood and Marrow Transplant and Cellular Therapy at Stanford University.ReferenceHosoya H, Bastidas Torres AN, Fernandez-Pol S, et al. Long-term follow-up of gastrointestinal CAR T-cell lymphoma: homing, clonal expansion, and response to cyclosporine. Blood. 2026;147(11):1191-1198. doi:10.1182/blood.2025031423

A pivotal JAMA randomized trial introduces an epigenetic twist to frontline therapy in high-risk DLBCL. Adding tucidinostat (HDAC inhibitor) to R-CHOP improved event-free survival (HR 0.72, P=0.02) and increased complete response rates (73% vs 62%) in MYC/BCL2 double-expressor lymphoma. Toxicity was higher but manageable.   A quiet but meaningful shift—targeting biology, not just burden.   #DLBCL #Lymphoma #Oncology #PrecisionMedicine #JAMA #ClinicalTrials

In this week's episode, Blood podcast editor Laurie Sehn interviews Drs. Edward Cliff on his latest research published in volume 147 issue 14 of Blood. Dr. Cliff discusses "Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries" which maps the mismatch between innovation and implementation across high-income and selected-upper-middle-income countries for US Food and Drug Administration–approved products and indications. 

It's Wish Week here on Newstalk, and we are highlighting the incredible work Make-A-Wish does in helping create life-changing wishes for children with critical illnesses…Seán is joined by Isabelle McCarthy, who was diagnosed with Hodgkin's Lymphoma, and her dad Brendan to discuss the wish she had been granted…Let's make 2026 the biggest Wish Week yet! Every cent matters. Donate online at makeawish.ie/donate.

In this week's episode, Blood podcast editor Dr. James Griffin interviews authors Drs. Steffen Boettcher and Robert Zeiser on their recent publications in Blood. Dr. Boettcher discusses "Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germ line ERCC6L2 disease", which provides insights to disease evolution by demonstrating that p53 loss can rescue BMF phenotypes caused by biallelic mutations in ERCC6L2, but at the cost of profound genome instability, increasing DNA damage and leading to the onset of aggressive erythroid leukemia. Dr. Zeiser discusses "Gastrin for the treatment of acute graft-versus-host-disease of the stomach", which delineates the protective role of gastrin in aGVHD of the stomach in mice and patients and provides a rationale for therapeutic use of pentagastrin in a clinical trial for patients with aGVHD.

Would like like to share feedback on this podcast? Or suggest another topic for us to explore? Click here, or email us at DocTalk@medstar.netOn this DocTalk episode, we chat with Dr. Jennifer Kanakry, the medical director of the Stem Cell Transplant and Cellular Immunotherapy Program at MedStar Georgetown University Hospital. Dr. Kanakry explains what types of lymphoma can be treated with CAR T-cell therapy. For an interview with Dr. Jennifer Kanakry, or for more information about this podcast, contact MedStar Georgetown University Hospital Manager Media Relations, Ryan.M.Miller2@Medstar.net. Learn more about Dr. Kanakry.For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

In this week's episode, we continue our journey through the relapsed/refractory myeloma space, with a focus on the role of bispecific T-cell engagers. Another incredibly important conversation that is so important in the current treatment landscape and one that you don't want to miss.If you haven't done so already, be sure to check out our CAR T episode.Content:- What are bispecific T-cell engagers? - How are they different than CAR T? - A discussion of the pivotal MajesTEC-3 trial (NEJM 2025) - What are key side effects?- How to sequence CAR T vs. bispecific T-cell engagers? ** This episode is sponsored by The Lymphoma, Leukemia and Myeloma Congress! To learn more and register for the meeting, visit llmcongress.com/podcast! Be sure to use our special TFOC code TFOC40 to save 40% off registration. ** Want to review the show notes for this episode and others? Check out our website. Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Youtube

When you're facing a diagnosis, a fear, or a season of waiting, it's easy to feel overwhelmed by the unknown. In today's episode, Tommy Jennings shares a powerful testimony of courage, peace, and unshakable faith as he battles Hodgkin's Lymphoma — a fight he's been in for six years. Tommy's story is raw, honest, and deeply hope‑filled. After exhausting every treatment option, he now lives in the tension of uncertainty — yet his confidence in Jesus has only grown stronger. His words, "Either way it goes, I win," will challenge and inspire you to trust God in your own battles. In this conversation, we talk about: What faith looks like when the prognosis isn't what you hoped for How to cling to God when you're waiting for answers Finding peace in the middle of fear, suffering, and the unknown The hope of Jesus when life doesn't make sense Why Tommy refuses to feel sorry for himself — and how his perspective can reshape your own Whether you're walking through illness, fear, or a difficult season, this episode will remind you that God is near, God is faithful, and God is still writing your story.  Watch on YouTube: Finding Hope in the Unknown: Tommy Jennings' Fight with Cancer Ep. 164 Contact Carol at CarolRoper.org/contact

In this episode, Blood Associate Editor Dr. Jason Gotlib discusses the Review Series "The New Wave of Targeted Therapeutics for MPN's", with authors Drs. Stefan Constantinescu, Ann Mullally, and Marina Kremyanskaya. This Review Series covers 3 areas where exciting advances are occurring. Dr. Constantinescu discusses “Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms” which describes how new ways to switch off JAK signaling are delivering a suite of new small-molecule drugs with potential. Dr. Mullally discusses “Novel strategies targeting mutant calreticulin in essential thrombocythemia and myelofibrosis” which reviews the biology of calreticulin mutations in myelofibrosis and ET and how multiple different modalities can be brought to bear against this mutant surface protein, including monoclonal antibodies, bispecific T-cell engagers, and cellular and vaccine therapies. Dr. Kremyanskaya discusses “Modulators of the hepcidin pathway in polycythemia vera and myelofibrosis” which outlines the major recent progress being made in controlling excessive erythropoiesis through pharmacological modulation of iron metabolism.

In this week's episode, we take a practical dive into the relapsed/refractory myeloma space, with a focus on the role of CAR T therapy for relapsed/refractory. In our next episode, we will continue on with a discussion on bispecific agents! This is a conversation that is so important in the current treatment landscape and one that you don't want to miss. Content:- What are treatment options for patients with relapsed/refractory multiple myeloma (R/R MM)? - What is CAR T therapy? And what role does it play in R/R MM?- What are the available options for CAR T for R/R MM?- What are the toxicity profiles of available agents? - How to choose between the options?** This episode is sponsored by The Lymphoma, Leukemia and Myeloma Congress! To learn more and register for the meeting, visit llmcongress.com/podcast! Be sure to use our special TFOC code TFOC40 to save 40% off registration. ** Want to review the show notes for this episode and others? Check out our website. Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Youtube

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs. Alexander Bick and Jorge Cortes on their latest papers published in Blood. Dr. Cortes, the current EIC of Blood Global Hematology discusses "Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in the ASC4FIRST Trial" wherein the planned secondary analysis showed a further efficacy advantage and a consistently favorable safety profile for asciminib relative to investigator-selected TKIs, especially second-generation TKIs. Dr. Bick discusses "Increased prevalence of clonal hematopoiesis in children with sickle cell disease" where targeted sequencing for CH mutations in 2318 children with SCD and 2957 controls and found that children with SCD have a higher prevalence of CH, and majority of CH cases identified were very small “micro-CH” clones, more work is needed to define the clinical significance of these clones.

Meghan Gutierrez, CEO of the Lymphoma Research Foundation, and Jennifer Branstetter, the Executive Director, North America Corporate Affairs at BeOne Medicines, join me to discuss the growing use of AI in patient care with a specific focus on individuals with lymphoma and other blood cancers. Emphasis is on the necessity of a collaborative, patient-centric approach to developing AI tools, bringing together patient advocacy organizations, healthcare professionals, and pharma partners to provide accurate information to patients. The goal is to serve a diverse population by providing personalized, accessible information to help patients have more meaningful discussions with their healthcare providers, not to replace the clinician's role. Jen explains, "We know that tens of millions of people are using AI tools in general, like ChatGPT, for health questions, including patients with blood cancers like chronic lymphocytic leukemia or CLL, they're all turning to the different AI tools that are out there. And from our perspective, we see this continuous growth of use, we want to make sure that the right healthcare information is getting fed into those AI resources and tools so that patients are getting the most accurate information possible."   Meg elaborates, "Many patients are using these AI tools to make sense of everything from their PET scans to their blood results, to some of the treatment language they receive in their clinician's or doctor's office. And one of the things that I heard recently from a cancer patient who had uploaded his scans and some test results into an AI platform. And he called me incredibly concerned. He was very concerned about his prognosis and the limited treatment options that he believed were available to him." "So when I pressed further, I found out that this AI platform was the only source of information that he had. So I became concerned when I recognized that the information he received was antiquated. So the treatment results and some of the information he was working from in this incredibly anxious and anxiety-provoking moment were 10 years old. And so in this case, antiquated information was as dangerous as inaccurate information. And both of these remain top concerns at the Lymphoma Research Foundation. And I think across our sector, as we see more and more patients using these tools and platforms to help educate them about their disease and their treatment options." #LymphomaResearchFoundation #LRF #BeOneMedicines #LymphomaAwareness #AIinHealthcare #PatientAdvocacy #BloodCancer #HealthcareInnovation #PatientEmpowerment #PrecisionMedicine #CLL #HealthTech #CancerCare lymphoma.org BeOneMedicines.com Download the transcript here

Meghan Gutierrez, CEO of the Lymphoma Research Foundation, and Jennifer Branstetter, the Executive Director, North America Corporate Affairs at BeOne Medicines, join me to discuss the growing use of AI in patient care with a specific focus on individuals with lymphoma and other blood cancers. Emphasis is on the necessity of a collaborative, patient-centric approach to developing AI tools, bringing together patient advocacy organizations, healthcare professionals, and pharma partners to provide accurate information to patients. The goal is to serve a diverse population by providing personalized, accessible information to help patients have more meaningful discussions with their healthcare providers, not to replace the clinician's role. Jen explains, "We know that tens of millions of people are using AI tools in general, like ChatGPT, for health questions, including patients with blood cancers like chronic lymphocytic leukemia or CLL, they're all turning to the different AI tools that are out there. And from our perspective, we see this continuous growth of use, we want to make sure that the right healthcare information is getting fed into those AI resources and tools so that patients are getting the most accurate information possible."   Meg elaborates, "Many patients are using these AI tools to make sense of everything from their PET scans to their blood results, to some of the treatment language they receive in their clinician's or doctor's office. And one of the things that I heard recently from a cancer patient who had uploaded his scans and some test results into an AI platform. And he called me incredibly concerned. He was very concerned about his prognosis and the limited treatment options that he believed were available to him." "So when I pressed further, I found out that this AI platform was the only source of information that he had. So I became concerned when I recognized that the information he received was antiquated. So the treatment results and some of the information he was working from in this incredibly anxious and anxiety-provoking moment were 10 years old. And so in this case, antiquated information was as dangerous as inaccurate information. And both of these remain top concerns at the Lymphoma Research Foundation. And I think across our sector, as we see more and more patients using these tools and platforms to help educate them about their disease and their treatment options." #LymphomaResearchFoundation #LRF #BeOneMedicines #LymphomaAwareness #AIinHealthcare #PatientAdvocacy #BloodCancer #HealthcareInnovation #PatientEmpowerment #PrecisionMedicine #CLL #HealthTech #CancerCare lymphoma.org BeOneMedicines.com Listen to the podcast here

In this week's episode of the Blood podcast, editor Dr. James Griffin interviews Drs. Christian Gorzelanny and Rebecca Leaf on their latest articles published in this week's issue of Blood. Dr. Gorzelanny discusses compelling evidence for a new mechanism that amplifies their proinflammatory actions in "Lipid nanotubes unmask neutrophils for complement attack", demonstrating the pathological role of this process in a range of inflammatory disorders in order to stimulate intense study of how to regulate nanotube formation for therapeutic benefit. In "Immune thrombocytopenia in patients treated with immune checkpoint inhibitors" Dr. Leaf and colleagues define the incidence, clinical features, and outcomes of ICI-induced immune thrombocytopenia. Showing that ICI-induced immune thrombocytopenia is associated with excess mortality, these data should provide an impetus to greater recognition and to protocolization of effective interventions.

An Ennis man who survived lymphoma cancer is now encouraging others to give back and support those facing the disease. Michael Doab was diagnosed in 2014 and underwent surgery and chemotherapy—but today, he's using his experience to raise awareness and funds for Irish Cancer Society ahead of Daffodil Day tomorrow (Friday, 20th March). He's been sharing his story and urging the local community to get involved and support those affected by cancer. Michael joined Alan in studio to explain just how much people's support can make a difference. Image © Clare FM

In this episode of the DIGA Podcast, we continue our Dermatology Crash Course mini-series with a high-yield discussion on cutaneous T cell lymphoma and mycosis fungoides led by Dr. Benjamin Cooper. We hope you enjoy! About the Dermatology Crash Course Series The Dermatology Crash Course is a DIGA Podcast mini-series focused on delivering short, high-yield episodes that cover foundational dermatology topics. Each episode features a dermatologist sharing practical insights to help learners develop confidence in recognizing and managing common skin conditions.Learn More:Educational links: Recommend educational resources by Dr. Cooper- Grenz zone podcast- Fitzpatrick Color Atlas and Synopsis of Clinical Dermatology---DIGA Instagram: @derminterestToday's Host, George: @georgepapadeas---For questions, comments, or future episode suggestions, please reach out to us via email at derminterestpod@gmail.com ---District Four by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/3662-district-fourLicense: https://filmmusic.io/standard-license---

Host: Darryl S. Chutka, M.D.  Guest: Stephen Ansell, M.D., Ph.D.  Non-Hodgkin's Lymphoma is a group of hematologic malignancies originating in the lymphatic system. There are over 60 subtypes of lymphoma with varying degrees of aggressiveness. It can present with a variety of rather subtle symptoms, often making the diagnosis challenging. Although Non-Hodgkin's Lymphoma is typically managed by a hematologist or oncologist, the primary care provider plays a role in its recognition, preliminary diagnostic tests and supporting patients through their treatment. What are some of the more common symptoms and signs of Non-Hodgkin's Lymphoma? Which ones should prompt an urgent referral, and what preliminary tests should we do prior to referring the patient? These are some of the questions I'll be asking my guest, Dr. Stephen Ansell, Chair of the Division of Hematology at the Mayo Clinic. The topic for this podcast is Non-Hodgkin's Lymphoma.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

“Cancer didn't just change my life; in a lot of ways, it saved it.” In this episode, Nick speaks with writer and cancer survivor Edward Miskie about identity, resilience, and rebuilding life after cancer. Edward shares his journey through alcoholism, a rare and aggressive cancer diagnosis at 25, and the emotional fallout of survival. He opens up about losing who he was, shedding old identities, learning to create a new version of himself, and the power found in asking yourself what you truly want. What to listen for: Cancer stripped away his sense of identity and derailed every plan he had for his life. Coping took many unhealthy forms, such as alcohol, casual sex, and escapism, etc. All attempts to feel “normal.” Humor, community, and intentionally creating fun moments helped him survive emotionally. After treatment ends, survivors lose their daily medical support system and feel like they're free-falling. “The question that changed everything for me was simply: What do you want?” Asking what we want puts us back in charge of our lives Whether you're in tune with your intuition or not, asking what you want will most often bring up an answer, even if it's surface-level; it's a start Taking charge of your life doens't always mean taking action first; it often starts with a simple question “Humor and fun helped me survive the darkest moments, even when it felt impossible.” Escaping or bypassing is never the answer to healing; however, a subtle mental shift can be just what is needed to keep moving Finding “fun” and humor in life often leads to quicker resiliency Life sucks at times. Why not have fun as best we can in every situation, no matter how dark or dire? About Edward Miskie Edward is currently celebrating 13 years as a sole survivor of a rare Non_Hodgkin’s Lymphoma with the publishing of his book Cancer, Musical Theatre, & Other Chronic Illnesses, available at Barnes & Nobel, Apple Books, Walmart, Amazon, and others. For the last 20 years, Edward has spent his life in NYC writing, producing, and performing. https://www.edwardmiskie.com/ https://www.remissionfilmfest.com/ https://instagram.com/edwardmiskie https://www.tiktok.com/@edwardmiskie Resources: Check out other episodes about life change from cancer Cancer Doesn’t Define Your Life, You Do, Embrace The Suck Unpacking A Five-Time Cancer Survivor's Journey With Shariann Tom Interested in starting your own podcast or need help with one you already have? https://themindsetandselfmasteryshow.com/podcasting-services/ Thank you for listening! Please subscribe on iTunes and give us a 5-Star review! https://podcasts.apple.com/us/podcast/the-mindset-and-self-mastery-show/id1604262089 Listen to other episodes here: https://themindsetandselfmasteryshow.com/ Watch Clips and highlights: https://www.youtube.com/channel/UCk1tCM7KTe3hrq_-UAa6GHA Guest Inquiries right here: podcasts@themindsetandselfmasteryshow.com Your Friends at “The Mindset & Self-Mastery Show” Click Here To View The Episode Transcript Nick McGowan (00:01.23)Hello and welcome to the Mindset and Self Mastery Show. I’m your host, Nick McGowan. Today on the show we have Edward Miske. Edward, how are doing today? Edward Miskie (he/him) (00:11.107)How are you? Nick McGowan (00:12.376)I’m good, I’m good. I know we’ve had just a little bit of technical issues getting things started, but here we are. I’m excited to talk to somebody who’s from the Northeast. I know when I was describing how the show would be, I was like, here’s kind of a Northeast can of how it’s gonna be. But we’re gonna talk about a pretty fucking heavy topic that sadly a lot of people either experience or know somebody that is going through it or has gone through it. And I fucking hate cancer and I know you do as well. So man, I’m glad that you’re here. Why don’t you get us started? Tell us what you do for a living and what’s one thing most people don’t know about you that’s maybe a little odd or bizarre. Edward Miskie (he/him) (00:51.36)Sure, okay, so I pay my bills working in corporate America, but outside of that, I’m a writer and I consider myself to be a producer in either live or TV film world. It’s been a long journey. I used to do musical theater and some TV and film, and here we are. Here we have landed in this kind of iteration of that life. thing about me that is kind of weird, bizarre. actually like, and this might be a little bit mild for you, but like, I consider myself more recently than not to be an introvert. And I always thought that I was an extrovert, but that was actually just because I was drinking enough to become an extrovert to kind of like, settle the introverted, introverted want to go home. And I felt kind of obligated to fight that and stay out and be around people and do all the social things. there is a point to which I really did like that. But it just turned me into an alcoholic. And so I stopped drinking and embraced the fact that I’m more of an introvert than anything. Nick McGowan (02:08.718)I don’t think that’s mild and actually man, that’s spot on with my own life. I think there are a lot of us that think, we have to do this sort of thing. Like we have to go out. Like people work in a corporate office, let’s say every Thursday night, everybody goes out to this one specific bar for happy hour. And they all talk about the one person who’s an idiot in their job or whatever else. And they all just do those things. And there are people that are like, well, I want to be part of that crowd. So I’m going to do that. I think that should even ties back to when we were kids. Like there are certain people that didn’t experience drinking in high school, others that were like, everybody fucking come with me. I got it. We’re going to the woods, you know? Edward Miskie (he/him) (02:37.654)No, it- Edward Miskie (he/him) (02:43.992)yeah. Little column A, little column B. But yeah, is especially like having, like I said, in theater for so long. Being in New York City, it’s very hard to be introverted in New York City. I remember reading something recently that was like, I’m actually an extroverted introvert in the sense that like, I am pretty comfortable in a social setting. I am very comfortable doing stuff like this. Nick McGowan (02:47.957)Yeah. Edward Miskie (he/him) (03:10.102)But if you throw me in a social setting where I don’t know anyone, I immediately clam up and disappear. it, that’s what the alcohol was for. You know, and then, and then COVID hit and that just spiraled out of control and then, you know, here we are. So, you know, that I think that is probably the weird thing about me that people might not guess if they know me. Nick McGowan (03:19.022)Yeah, yeah, lube you up. Nick McGowan (03:32.504)Well, how long have you been sober now? Edward Miskie (he/him) (03:35.632)it’ll be two years end of March. So like year and a half. Nick McGowan (03:39.822)Cool, nice. That’s not a thing that most people kind of just bring up, you know, unless you’re like, I don’t know, being grossly boisterous about it. Like, hey, I stopped drinking a year and a half ago. The fuck, we’re not even talking about that. Yeah, like, well, okay. Or CrossFitters. Yeah, or Vegan CrossFitters, watch out. Edward Miskie (he/him) (03:47.99)Look at me! Right, it’s like vegans. I’m vegan. or vegan, God, the worst. Yeah, no, I mean, it’s, I think I said to you offline, like, I literally wrote a book about my life that is not does not put me in a good light. And so I just have a very low threshold for things that like, I’m sensitive about talking about. So like being a full raging alcoholic, that’s nothing. Nick McGowan (04:19.534)Sure, yeah. That was the fun times. Yeah, that’s funny. I’m sure there are more people than not that listen to this that have like, at some point thought maybe I have a little bit of a problem. And maybe that was the end of it. You know, like, I realized at one point, I’m drinking a lot. And this isn’t helping me. It’s actually stopping me from doing things. Like I remember one time telling myself, I’m gonna go to the gym today. It’s like, no, you’re not. Edward Miskie (he/him) (04:22.984)Right, miss those days. Nick McGowan (04:48.402)It’s 11 o’clock and you’ve already had two drinks. I was like, I’m not going to the gym today. And the next day being like, that sucks, man. That’s gross. And I hate it or whatever. And I was like, I don’t even want to go outside because I’m making these choices to do this. So, but if you get to that door, you can then make a choice through that. Like we’d even said, kind of offline, like you had to get to a door to be able to be where you’re at today with all this. But let’s break down the alcoholism in a sense, going out and being around with people. Edward Miskie (he/him) (04:52.277)Oof. Nick McGowan (05:18.094)Excuse me, being in the industry, being in the conversations, all that sort of stuff can be weird for people if they don’t have a drink. And going out after the fact when you’re no longer drinking, it’s like, you just don’t want to stand here with this thing? Edward Miskie (he/him) (05:34.027)Yeah, it’s like it that that part I’m fine with. And like up into a certain point, like when people start getting shitty, then I’m that’s my cue to leave. That’s usually the barometer I go by. I’m not like triggered being in a bar. I’m like, cool to be around it. It’s not a big deal. I just don’t like it just makes me feel gross. And I just don’t want to do it. It’s it’s when I’m around people who are getting a little unruly and on the drunk scale that I’m kind of like, okay, well, that’s my cue to go because we’re no longer on the same plane. Nick McGowan (05:36.686)Good. Nick McGowan (05:43.726)Sure. Nick McGowan (05:52.302)Yeah. Nick McGowan (06:02.442)Yeah, Irish exit your way on out. I’m glad that you say that there are certain people that are they’re hesitant to stop drinking or stop doing whatever that thing is that they do, because that’s kind of how they hang out with those friends. That’s how they hang out their family, you know. Edward Miskie (he/him) (06:05.246)Yeah, just like, good night guys, bye! Edward Miskie (he/him) (06:20.596)I mean, yeah, I mean, that’s that’s part of the reason why I drank a lot because that was my social social circle. And it was just kind of like, well, if I stopped drinking, like, they’re not going to ask me to come out with them anymore. And like, low key, that’s what happened in the long run. But like, you know, it was it was a huge buildup. You know, I started really kind of drinking pretty heavily in like, I don’t know, 2010. I drank my way through chemo, I drank my way through my 20s and my early 30s. And then I just hit a point where I was like, I don’t, I want to see if I can go a certain period of time without it. And like it was during COVID, I had actually built up my tolerance, like an actual fucking champion and blew through a bottle of Jameson within like four or five hours. And I wasn’t drunk and I wasn’t hung over the next day. And that was kind of like the whole, hmm. Nick McGowan (07:13.838)That’s a sign. Yeah. Edward Miskie (he/him) (07:14.71)Okay, maybe I should stop now. And then like my doctor was like, your liver numbers are out of control. What are you doing? So we had we had to do a quick course correct, but I wouldn’t I never actually went fully sober because of that because I was like afraid of the social component of it going away. So I would do like 100 days here 100 days there 200 days was I think 210 days was as long as I had ever gone. And then this spring or spring 2024. Nick McGowan (07:22.382)man. Edward Miskie (he/him) (07:43.127)I just was like, I’m gonna do a year. That’s the longest I would have gone ever. So let me try that and let me go for a year. And then a year hit and I was like, oh, like, I should like ceremoniously break this and then I’ll never be sober for more than a year. And like, I’ll just go out and have one drink and it’ll be totally fine. the day came and went and I was like, I don’t want to. I’m good. So here we are a year and a half later and I’m still. Still on the sober train. Nick McGowan (08:13.358)And that’s cool. mean, for everybody that’s listening that is having one or six you Damn. All right. So, yeah, well, I’m gonna start that over again, because at least now I know that there’s a problem. Because like I said, last episode, I was still like, yeah, sure, with like the laptop up. So I’m gonna clip this part out. All right, so three, two. So whether it’s one or six drinks, I mean, the people that are out there kind of thinking like, I know I have probably a little too many, but I don’t really think that there’s much of a problem. I think there’s stuff where we have to think about Edward Miskie (he/him) (08:25.91)It’s all good. heard one or six. Great. Nick McGowan (08:55.03)Like you said about your liver, like your liver enzymes are probably crazy that you don’t know that you potentially have fatty liver that you have to deal with now. And there are different things that could come up. Like, I don’t know, I don’t want to sound like somebody that’s like, you shouldn’t drink and finger wag and all that. But it’s like, in some ways, the older we get, the more that we can look at the shit that we did when our twenties and thirties and go, my God, what’s going on inside my body right now? Like you kind of just blew straight past it that you drank through chemo. Time out, back to the chemo. Give us context here. Edward Miskie (he/him) (09:29.534)I had cancer. It was a very rare non Hodgkin’s lymphoma. There were only about like 900 or so cases of it reported worldwide at the time. It’s called rare and large B-cell Burke. It’s like non Hodgkin’s lymphoma. It’s very aggressive. You could watch my tumor grow. It was the grossest thing in the world. And it was a very dire emergency situation. And I think maybe like two or three rounds of chemo in and I just asked, it was two, was round two. And I asked my oncologist if I could have a drink and she was like, yeah, just one or two, but don’t go crazy. And then I promptly left the hospital and went to my friend’s bar and went crazy and had like doubles the whole night. it was, and like she knew that I had was going through, like going through it and she was trying to help and be like, free alcohol, take it, whatever, whatever, whatever. And then just, you know. that’s that kind of like opened the floodgates of like, you can drink during chemo. That’s fine. And and I did. Nick McGowan (10:31.03)I mean, for anybody that drinks even slightly, they’re probably gonna listen and be like, of course you’re gonna drink. I would drink. Edward Miskie (he/him) (10:38.558)Well, right. What my justification of it was like, well, you know, liver wise, like it’s not chemo. This is like water at this point. So like we’re good. Nick McGowan (10:50.672)the things that will justify, know, like, you know, other poison or this poison I’ve been used to for a while. Why do I use one as a back, you know, like a piggyback? Thank you. It’s a dessert. man. Because you’re piling alcohols in. Edward Miskie (he/him) (10:53.598)Right Actual poison or we’re curated poison. Pick one, you Yeah, the liver is like, oh well, that’s not methotrexate. So cool. We’ll have a little a amuse-bouche Edward Miskie (he/him) (11:16.926)yeah yeah yeah like what a respite from chemo was was bourbon Nick McGowan (11:19.924)Yeah, jeez, jeez. I mean, it makes sense. Part of the reason why I have the show is to talk about those super dark times, like the times where you’re sitting there. Like, I’m sure I’m not, I’m not you, obviously. So I can’t think and remember this, but I can almost picture you sitting there with a glass in your hand, a couple fingers of scotch or whatever it is, thinking like, huh, this is where I’m at right now. And like, what a fucking time to think about all that stuff and still put that shit in your body. Cause you, in some ways I’m sure you’re like, I just want to feel a little happy, a little something. Edward Miskie (he/him) (11:54.433)Well, it wasn’t even so much a question of feeling happy because like I was 25 when I was diagnosed, right? So like I was still a young person, relatively speaking. I mean, I was a young person. I’m almost 40 now. So like, you know, whatever. But it wasn’t so much about like having that introspective moment of like, I guess this is my life now. It was more like, fuck this. I’m going out and having fun. This shit isn’t going to stop me and I’m going to drink my way through this. And it it very quickly became a coping mechanism along with a number of other things. And like, and it’s a big narrative that I carry through where it’s just like the coping mechanisms of having cancer and then again, the coping mechanisms of surviving it. You know, alcohol was certainly one of them. I had tried like pot for the first time during this period of time. And that was like pre like retail available. So like you were just hoping for whatever the dosage was, and I didn’t know shit about dosage. So like, the friends that I had at the time, like baked brownies. And like, back then, you just like threw a little nug in some butter and hope for hope for the best. And they were bombs. Like, and they were going off, especially if you were mixing. But you know, it was like those two things that like indiscriminate sexual strangers, because I just wanted to feel like hot and normal, even though I was like bloated and bald from chemo. So Nick McGowan (12:50.848)Yeah. Nick McGowan (13:00.886)Some of them are bombs. Yeah. Edward Miskie (he/him) (13:18.526)It was one of the many coping mechanisms that I developed during that period of time. Nick McGowan (13:24.096)So I don’t want people to ever go through anything like this ever. I mean, it sucks that we people go through really, really tough and difficult times, but I mean, it also shapes us. Like going through these really trying and like devastating times, you get through it, you are ultimately changed no matter what. Like I have not been through cancer personally, but I’ve had lots of family and different friends and people that I’ve known that have had it. And it almost seems like it’s like one in like every other person at this point. But then again, like all the stuff that we go through, be it cancer, be it some drastic change, be it some career you’ve had for 15, 20 years and you go, what the fuck am I doing? I didn’t want to be here 25 years ago. Whatever those changes are, that shit can stop us from making additional changes. You were kind of forced in a sense with cancer. Like you had to deal with it. You could not. Yeah. Edward Miskie (he/him) (14:19.604)Right, there was no option. I was told I wouldn’t live past 30 if I didn’t do anything. Nick McGowan (14:24.854)But as a 25 year old, you’re right. I mean you’re a kid at that point. I can’t remember being 25. Like I know every fucking thing in the planet. Now you look back and like, oh. Edward Miskie (he/him) (14:28.682)Yeah. Yeah. Edward Miskie (he/him) (14:32.992)my god, I was a, I was a dumbass. Like what and then you give me cancer, like, of course, I’m gonna the dumbassery is going to continue through it. And in a lot of ways, even though like, even though it was awful, cancer saved my life, and it changed it in a good way. And that took a long time to kind of come to terms with that wasn’t like, my god, you’re cancer free. And I’m like, thank god that happened. I didn’t want to talk about it for years. It just became like a thing I would drop into conversation and passing where they’d be like, where were you for the last year? Like, I had cancer moving on, you know, and it just didn’t want to, I didn’t want it to become my personality. And as I, as I’ve aged, I’ve kind of made a little mini career out of it and has become my personality. You know, I probably, I was probably fighting it to be so honest with you. Nick McGowan (15:24.874)Maybe you kind of knew it was coming, you know, like, yeah. Along with being an extrovert, which you’re not, and like fighting that as well. man. Yeah, that, I can’t imagine how something that drastic couldn’t change you, but I also think that there’s, the purpose that we have in our own lives was part of us being here and what we were brought into this planet with. Edward Miskie (he/him) (15:30.378)Ha ha ha! Right, right, yeah. Nick McGowan (15:53.12)but everything will shape us. The environment shapes us, technology shapes us, all this stuff. So what a cool thing for you to tie film along with your journey. Like you and I connected because you’re looking for people that can talk about their cancer story in basically a real YouTube short clip that’s going to be part of a documentary that will ultimately help people even if they go, I’m going through this now and I don’t know what to do. Here’s some sort of I’m not alone feeling from this. Like you unfortunately had to go through this shit to ultimately be able to do this and be able to help a lot of people. So talk to us a bit about getting up to the point of like, want to create a documentary, to create a film festival and then actually doing something with it. Edward Miskie (he/him) (16:41.558)Well, I’m always doing something. Friends and family know that I’m never sitting still. Grass can’t grow on a rolling stone or moss can’t grow on a rolling stone, whatever that phraseology is. That’s me. And it was right after I was told I was cancer free that I just, I think that, and I’ve learned this to be kind of the general consensus that you’d think that you’re just going to go back to the way that your life was before. And it’s like, oh great, this is done. know, okay, we’re finished here, Wrinkle in Time, we’re gonna meet me, this me is gonna meet me back here where I am currently, and we’ll just go from there. And that is effectively not what happens. I fought that for years, where I thought that I could just shove myself back into the life I had before, and it always felt off. And maybe to the outsider, who is not me, it looked like I successfully did that, you know, I was a working actor for a long time. And I was going through the motions of the life that I had before, but the entire time I felt so out of place and I felt off and I couldn’t figure out why. And as I started to speak to other people who had been through the cancer experience and come out on the other side, every single one of their stories was the same. I can’t stand the people I’m around. They’re irritating me. I don’t want to go to work. I mean, that’s a normal feeling, but like in a different way. where it’s like, what am I fucking doing? Like, I don’t want to do this. And it shifts your relationship, relationships not only with other people in your life, but with yourself. And there isn’t a whole lot of conversation about it. There’s not a whole lot of resources for it. And so what I wanted to do, the more and more I talk about this independently, whether it be on other podcasts or whether it be through something else I’m working on, it’s why I wrote my first book is that I want to have the conversation not only of like the hard parts of having cancer, because I think a lot of times people just look at you like a cancer patient, and you’re not really a person anymore. And so the conversations of relationships, dating sex really, then and, you know, body image and everything else kind of go away. Because, you’re a sick person, you shouldn’t be fussing about that. Okay, well, I was a 25 year old guy, like, and I’m very vain. So like, Nick McGowan (18:59.734)Hmm. Edward Miskie (he/him) (19:06.654)Of course, I was going to be thinking about this. and so those conversations paired with the after cancer conversations and how your life just is complete, a complete unrecognizable thing that like you’re existing in and it’s like it’s like dreams, you know, like when you have a dream and in the dream, you like understand that you’re in your house, but it doesn’t look like your house. That’s what it’s like you come out and you’re like, I recognize everything, but I feel so displaced. Nick McGowan (19:08.853)Hmm. Nick McGowan (19:28.778)Mm-hmm. Edward Miskie (he/him) (19:36.363)and I don’t recognize anything that’s happening. And so you spend a lot of time like I did trying to grasp to get back at that desperately and in so many different ways to try and feel the way that you used to feel before you had cancer. And that’s just not going to happen. And my, I think my impression that I would like to leave with people who are maybe newly cancer free or are presumably going to be soon is that like just fucking kill off the person that you were before early. Because the sooner you let go of that person, the sooner you can create a new one that is going to be better and have better context and better understanding of your life and your wants. And it’s very much a clean slate. It’s almost, medically speaking, I had a stem cell transplant. That’s not the case with everybody else, but medically speaking, like my immune system was a little baby. Nick McGowan (20:08.694)you Nick McGowan (20:33.45)Hmm. Edward Miskie (he/him) (20:33.576)And so like, in a very literal sense, like my body was infantile and like, didn’t look at but you know what I mean? Like on the inside, the actual clock running on the immune system was was a little baby. And so like, I should have really treated myself the same in the sense that there I have no history from that point on, there’s no history, there’s no context to start over. And I wish I would have done that sooner. Nick McGowan (20:41.366)you Nick McGowan (20:52.904)Yeah. Well, it sounds like it’s almost like shedding skin in a sense. Like, but that. Edward Miskie (he/him) (21:01.224)yeah, 100%. And especially in almost in a literal sense too, not that your skin is like falling off or unless you’ve had radiation in which case then yes it is. there are pictures, they’re not nice. But like you don’t look the way that you did before cancer really ever again. You know, and like, relatively speaking, I don’t think I look I’ve ever looked at the way that I did before cancer ever again. And maybe that partially had to do with my age and getting older and whatever. But, you know, you you go into it looking one way and then you get in there and you’re completely wrecked and you look very different during and then after it’s like a rebuilding stage and you bounce back and think your hair comes back curly or sometimes it comes back white or sometimes it doesn’t come back at all and There’s so many different versions of how you change through that whole process that like on the other side, it’s just like, what skin am I wearing? Who is this? Nick McGowan (22:07.846)And with that, it also changes you, you know, as the soul and the being inside. What a cool thing to think about from the perspective of, if you’re changing, you’re changing. So go with it. But that’s not a thing you could have really, I don’t know, I’ve only known you for a little bit, but like, I’m sure somebody at 25 and they’re like, you’re gonna love the person you’re gonna be, probably would have started off with fuck you and. anything after that would have just been how you felt about yourself in that moment right then and there. As a 25 year old kid too, you are still forming who you think you want to be. Even if you’re a little further ahead in where you are, like you’re still a couple of years ahead of maybe somebody who’s 22 or whatever. But you have this idea in your head of this is where I think I’m going. And then that all changes. So for you now to be able to look back and say like, all right, well, I could have flown or like enjoyed that a little bit more and gone with it. I think that’s crucial for people no matter what age. you also have different points. Like 30, you look a little different. 35, you feel a little different. 40, your knees just fucking hurt. Yeah, exactly. And you’re like, what happened? Like, why is my back hurting? I slept for eight hours. That was the problem. But like life just happens and. Edward Miskie (he/him) (23:20.958)And you start to look a little different too. Edward Miskie (he/him) (23:30.422)Yeah. Nick McGowan (23:32.81)I think we have to look at ourselves in the mirror differently at different times anyway. But for those people that are, I don’t know, about to go through something like that, not even just cancer, because I think this kind of ties across different major shifts and changes. What advice would you give to them to be able to say like, hey, keep on that track, but here’s how it go about it. Edward Miskie (he/him) (23:57.653)mean, I know several people who have written books that are like the blueprint to going through cancer. And I think that is helpful. And there’s certainly a place for that. I think I think that there is no blueprint and no guidebook because everyone is different. And every circumstance is different. And every prognosis is different. And the treatment I get is not going to be the same treatment that someone else gets. And so it’s very difficult to kind of articulate like, do this. And the only And I mean, as unfun as the realities of cancer are, and the need to like basically force feed yourself so that you have strength enough to get through it and and like all that crap, even though you don’t want to. I think, I mean, the during the during portion, like, try to have fun, like, really try to have fun. I would invite friends over to like my hospital room and we have like pizza parties. with hospital food. Like it was fun. Like it was a shitty circumstance. It was fucking terrible. But like we made the best of it. And being surrounded by friends and family really helped that. And it’s certainly a way to fight it. You know, like there’s only so much fighting you can do in a hospital bed and like with doctors and nurses around you and this, that and the other. like, try to have fun, make the best of it. Like that’s, and I feel shitty saying that, you know, because like facing that if you would have if you would have said if you would have told newly diagnosed 25 year old me to like have fun and be like fuck you you dumb cunt what are you talking about? So that that’s I feel like that’s a pretty hard bill to swallow and I apologize if that comes up. Oh my god you have cancer have fun. Nick McGowan (25:43.484)I mean. Well, I mean, there are things like, I think you can go through shit where you can tell somebody like, man, it’s going to be rough, but here’s what I learned from it or whatever. I’m glad that you went to them. You don’t have, I guess, the right or the authority or all the information even to be able to say, here’s the exact blueprint. Because that is never the thing. Like context and everybody’s situation is always different no matter what it is. But for you to be able to think back to yourself of like, hey, go have fun. Okay, you probably would have told yourself to go fuck off. In all reality, like you’re still right because you’ve been through all that. And there’s still stages just like grief, just like anything else, you go through all those stages. But then with the clarity, here you are doing these things. So with the people that are on their path towards self mastery, maybe you’ve had cancer or they’re in remission or they know somebody that’s had cancer, what sort of advice would you give to them as they’re on their path towards self mastery? Edward Miskie (he/him) (26:46.666)Who? I might have to just talk this one through. think my first reaction is when you have cancer actively, there is no path to self mastery because every single day is just a curve ball. And I feel like that sounds a little womp-womp and I don’t mean it to, but the last thing on my mind when I was in treatment was like, how can I self master? Self master bait, maybe, but that’s a different conversation. but I do think that there is, there is room to like, live in the active cancer space during treatment and like, make sure that you take moments to appreciate the people around you. And to recognize those who are helping you from a from a good place, because there are certainly people that are going to show up that are not there from a good place. And that’s much longer conversation, but I would say like be fine find a way to be present and acknowledge the people around you and Appreciate the fact that they’re there Nick McGowan (28:00.38)seems important kind of no matter what’s going on but probably really critical for you to look at in such a heavy time of like what the fuck I could imagine most times you can go in through cancer you just don’t want to even anything let alone have fun Edward Miskie (he/him) (28:11.734)you yeah. No, when I’m listening, I’m not trying to paint this picture that like everyday was rainbows and sparkles. Like it certainly was not. But like there, there were definitive points where I made a purposeful decision to have fun, or do something that was like really out of the ordinary from my day to day. And one thing like, maybe this is off topic, but one thing that I do want to add to the whole transitioning out of cancer thing is like, the again, the misconception of what that Nick McGowan (28:23.702)Sure. Edward Miskie (he/him) (28:46.64)looks like, right? You know, like you think you’re cancer free, you’re told that you’re cancer free, and everything is going to be amazing. And that you’re you get to go back to your life, right? But I think what people don’t understand, and they couldn’t understand, because they haven’t been in that situation, perhaps, is that like, when you’re being treated, all of the nurses and all the doctors and all the social workers and all the people running, you know, medical studies and whatnot that you inevitably get shoved into, are like a very concrete support system. And when you’re told that you’re cancer free, all of that goes away, essentially overnight. And so that’s like, it’s another contributing factor to looking around at your life and being like, I don’t know what to do, because you’re also free falling. You’re free falling from like this network of people that have been holding you up for however long and telling you where to go and what appointments to go to and what to eat and what not to eat and how to take your medication and when to take it and like every single moment of your life is dictated and then all of sudden it’s not. And that’s like, again, like a bomb going off, like where am I? What do I do? How do I get up in the morning? What do you mean I don’t have any appointments? And then in like a really kind of sick, twisted, fucked up way, you’re like wishing something would go wrong so you could go back to the hospital to see your doctor and be like, and feel normal because that has become normal. And they’re like, it’s it’s a minefield at my five year cancer free appointment, my oncologist, and I didn’t know this, told me that because I hit five years, I no longer need to see her. And like, you’d think like, my god, I hit five years. That’s great. I cried because I was going to miss her. And like, she was great. I loved her. But like, talk about like an unexpected reaction of like, what do mean, I’m not going to see you anymore? Nick McGowan (30:28.502)Mm. Edward Miskie (he/him) (30:39.24)It like very much was like a weird fucked up breakup. Nick McGowan (30:42.602)Hmm. And a very heavy time of your life. Like these relationships that, yeah, that’s, that’s crazy. I, people that don’t have situations like that don’t think about it. that way, I mean, it can almost be like, some jobs that you’re in, you can be familial and there’s some that like push too much of that, but like you work, you work a lot with people or groups or whatever. And then somebody’s just gone or the whole group ended or whatever. Like we all have those little situations at times, but Edward Miskie (he/him) (30:46.154)Yeah. Nick McGowan (31:12.874)the longer that stuff goes and the heavier it is, I feel like that just makes a ton of sense where it’s like all of that just compounds and like this piece of concrete of this is a giant chunk of your life. And these all mean a lot to you specifically now, but God going forward, you’ll have memories for the rest of your life because of all that stuff. Tevi, yeah, man, I’m glad that you bring that up. So thank you for that. And this has been. Edward Miskie (he/him) (31:33.782)for better or worse. Edward Miskie (he/him) (31:39.521)No, of course. And I do want to comment, sorry, I do want to comment to the self mastery thing. One thing I do remember doing, and I still do it now, and I actually end up yelling at people about this too, whenever you kind of like hit a place where you don’t know what to do, you you hit a fork in the road or some major thing changes in your life. And this was kind of a later on during that period of time thing, but I’ve carried it over to now and it’s like kind of the default thing that I do. is I asked myself what I want. And it’s like, it’s like, it has to be a rapid fire response. It cannot be like this existential, like I sat down and journaled about this for five hours, like it has to be like the look at yourself in the mirror and be like, what do you want? Or just like, write it down. I want blood and the first thing that comes to your mind. And I used to, I used to journal a lot more than I do now. But I would have I have pages and pages and pages of like, what do you want? I want I want I want I want I want and I would just make lists and it’d be stupid shit like I want a coffee. I want a car. I want money. I want better hair. I like you just write it down. And that’s like the very general version of that. But I think the more specific version of that is like if you’ve hit a crossroad, you have to ask yourself what do you want? Because so many of us end up acting Nick McGowan (32:42.079)Mm-hmm. Edward Miskie (he/him) (33:02.642)in the shadow of what other people want or what other people expect of us. And that just takes us farther and farther and farther away from who we actually are. This is something I can speak to specifically from cancer. But it’s, it’s something I can also specifically speak to because of being in the entertainment industry, where you are expected to be something you’re not necessarily or you get shoved into a box that like you have to exist in or you don’t work. And I wish I would have had this practice a lot earlier to just be like, what do you want? I want this. What do you want? I want this. if we’re getting a job offer, okay, look at it. What do I want out of this? What is this going to do to serve me? And I think the, the, what do I want situation has really shaped the last couple of years of my life. My life now looks Nick McGowan (33:53.718)Hmm. Edward Miskie (he/him) (33:56.745)exponentially different than it did three years ago, and it’s because I just really sat down with myself and just kept asking me what I wanted. Nick McGowan (34:05.098)Yeah, that’s a good point. think for anybody who, trust their intuition or the people that are real heady and think about things a lot. mean, there are certain people that they have to go off their gut instincts. Like, I’m a sacral lead person, so I even do it with dinners. Like, what are we having for dinner tonight? Sushi? Nah. Thai? Nah. Burgers? Yeah. Or whatever it is. It’s like to have that. But I think even if people can just sit down, and you have to think through things all the times or you have to feel through all of it, just asking yourself that of like, what do I want? There’s something that’s gonna come up, always. I’m glad you pointed out like the normal human shit of like, I want a coffee. Yeah, that makes sense. Cause like that’s what you fucking wanted, right? Edward Miskie (he/him) (34:46.068)Yeah, great. Right. And I think a lot of us, especially people who are over thinkers, I’m related to some of them. But like, there just is so much hesitation. And that takes up so much time when you think too hard about what the answer is. And I think that comes from being a people pleaser and wanting to come up with the right answer that everyone else will also be happy with. And like, Nick McGowan (35:02.784)Mm-hmm. Edward Miskie (he/him) (35:13.174)Again, I know if it’s age, I if it’s cancer, it’s probably a combination of both, but I don’t give a fuck what other people want. I don’t. This is the path that I’m going on that I’ve decided that is right for me, and I don’t give a flying fuck who has to say what about it. Like, you want to pay my rent? Great. Then you get to decide what choices I make. Nick McGowan (35:34.144)Hmm, man, I guess even on that note, the people that are kind of in a spot where they’re like, well, I work for somebody and I have to do what they want me to do because I also need to take a paycheck from them to pay for my mortgage and whatever else. I think we can still do that in a balancing way, but we have to ask ourselves at the basics. Like, what do I want right now? I don’t want to be at this job anymore. So start with that. Or I want to do something different or whatever. Yeah. Edward Miskie (he/him) (35:50.198)100%. Edward Miskie (he/him) (35:56.151)Great, right, then do something else. know, complaining will only get you so far until you actually have to like do something about it. Right, right, right. Well, and that actually ties into like the, I don’t remember what the prompt was in the, before when we were talking offline, but like I literally have a Post-It note on my desk. Nick McGowan (36:06.358)Or it’ll get you to Thursday’s and happy hour and then you can play with the group with him. Edward Miskie (he/him) (36:25.556)that says stop listening to other people telling you what you can and can’t do, what you should or should not be doing, what you are and are not capable of. They do not know you. Stop waiting. Start doing. Fuck them. That is literally on my desk. Nick McGowan (36:39.926)Period. Nice. I love how we all figure out the little things that work for us. Like, yeah, this is going to have this note right here. And yeah, like you get power from it. Edward Miskie (he/him) (36:54.807)yeah, I post- I post the notes all over my apartment. Nick McGowan (36:57.44)Good shit. Man, it’s been awesome having you on. I appreciate you being here. I appreciate you going through the stuff you’ve gone through and setting up the festival and all that stuff. It’s important work you’re doing, man. So before I let you go, where can people find you and where can they connect with you? Edward Miskie (he/him) (37:13.362)you can find, sorry, I just like glitched out. was like, wait, what? You can find me on Instagram or TikTok at Edward Miskey. Also the film festival is called the remission film festival. It is the only festival of its kind that is operating now that is specific to cancer survivors and those impacted by cancer. Everyone who submits to it has a story that they have told through film. And you can find that at remission Film Fest on Instagram and the website as well, which is just a dot com. And that’s and we talked about a book for a hot second. That’s Cancer Musical Theater and other chronic illnesses. And the other book will be coming out later, but we’re not going to talk about that just yet. Nick McGowan (37:57.477)Awesome man, well again it’s been a pleasure having you on, I appreciate your time today. Edward Miskie (he/him) (38:01.025)Thanks anytime.

In this week's episode, Blood editor Dr. Laura Michaelis interviews authors Drs. Marion Falabrègue and Ajai Chari on their papers published in volume 146 issue 24 of Blood. The work of Dr. Falabrègue and colleagues in "Intestinal hepcidin overexpression promotes iron deficiency anemia and counteracts iron overload via DMT1 downregulation" indicates that iron absorption from the apical surface of enterocytes can be modulated through manipulation of the hepcidin-DMT1 interaction, opening new avenues for research and therapeutic manipulation. "Talquetamab plus daratumumab in multiple myeloma" features a phase 1b/2 trial of 65 heavily pretreated patients with MM, where Chari et al combined daratumumab and talquetamab, a GPRC5D-targeting bispecific antibody, reporting depletion of CD38-expressing regulatory T cells following daratumumab and impressive efficacy, with an 80% overall (57% complete) response rate and median progression-free survival of 23.3 months. This regimen is now being evaluated in a phase 3 trial. 

Host: Darryl S. Chutka, M.D.  Guest: Stephen Ansell, M.D., Ph.D.  Hodgkin's Lymphoma is an uncommon but very curable malignancy involving the lymphatic system. It most commonly presents in young adults as well as middle-aged and older individuals. Although Hodgkin's is generally managed by hematologists or oncologists, the primary care provider plays a major role in its recognition, hopefully leading to a timely diagnosis and eventual staging. What are some early signs of Hodgkin's and what preliminary work-up should we do prior to referring the patient for definitive care? How do we monitor those who have had successful treatment of Hodgkin's? These are some of the questions I'll be asking my guest, Dr. Stephen Ansell, Chair of the Division of Hematology at the Mayo Clinic as we discuss Hodgkin's Lymphoma.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Glenn Sturm shares his experience of being diagnosed with aggressive T-cell lymphoma in 2009, initially dismissing the news as a prank. He describes his approach to handling the diagnosis by conducting research and assembling a team of medical professionals, eventually connecting with Dr. Foss at Yale, a leading expert in his type of cancer. Glenn emphasizes his background in building teams and his natural inclination to collaborate, which he applied to his cancer treatment strategy. Glenn shares his personal journey with cancer, highlighting how defining himself through helping others has improved his well-being. He discusses his ongoing chemotherapy and his work on multiple books, including a novel and a book about a multifaceted approach to cancer treatment. Glenn also mentions his commitment to donating proceeds from his astrophotography and photography to Children's Health, emphasizing the importance of teamwork and communication in his cancer treatment. Key takeaways Glenn Sturm has been living with T-cell lymphoma for 18 years, receiving continuous chemotherapy treatment Multidisciplinary cancer care approaches can reduce mortality rates by 18-90% compared to siloed approaches Glenn advocates for building a comprehensive healthcare team that includes specialists beyond oncologists Glenn's upcoming book "More Than Hope" focuses on integrated cancer care approaches Glenn emphasizes the importance of celebrating life and helping others despite health challenges NIH studies show that multidisciplinary approaches to cancer treatment significantly improve survival rates To find out more about Glenn's work visit glennsturm.com Visit ConfidenceThroughHealth.com to find discounts to some of our favorite products.Follow me via All In Health and Wellness on Facebook or Instagram.Find my books on Amazon: No More Sugar Coating: Finding Your Happiness in a Crowded World and Confidence Through Health: Live the Healthy Lifestyle God DesignedProduction credit: Social Media Cowboys

Show notes and links: www.chrisbeatcancer.com/how-carl-mason-healed-stage-iv-lymphoma-after-treatment-failed